Medical AuditNCT03125278
Patient Knowledge of Medication Indication
An observational study of Medical Audit, run by HealthPartners Institute at 2 sites in United States.
Trial summary
This is a study to compare patient knowledge about the indications of their medications between two sites. Regions Hospital has a population of patients that receive the medication indication on the label for any new or changed medications at the time of patient discharge. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Medical Audit
- What is being tested?
- Medication knowledge
- How many people
- 40 participants
- Where
- 2 sitesUnited States
- Study dates
- 11 Apr 2017to 31 Oct 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population will be patients recently discharged from the hospital with 1 or more new or changed medications.
Who may be able to join
- Hospital Medicine (HM) inpatient being discharged to home
- Patient being discharged with ≥ 1 new or changed medications
- English speaker
Who cannot join
- Inpatient being discharged to nursing home or TCU facility
- Patient being discharged with no new or changed medications
- Non-English speaker
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Brigham and Women's Hospital
Boston, Massachusetts, 02115
Regions Hospital
Saint Paul, Minnesota, 55101
About this study
This is a study to compare patient knowledge about the indications of their medications between two sites. Regions Hospital has a population of patients that receive the medication indication on the label for any new or changed medications at the time of patient discharge. Brigham Women's Health follows a standard policy of discharge medication labels including the name of the medication and instructions for use without any indication of what the medication is intended to treat. Consented patient will receive a phone call where researchers will ask about which medications they are taking and other questions about those medications.
The study population will be patients recently discharged from the hospital with 1 or more new or changed medications
- Conditions
- Medical Audit
- Being tested
- Medication knowledge
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Medication knowledgeOther
Participants will be asked questions over the phone about their medications
| Study group | Role | What they receive |
|---|---|---|
| Medication indication on the label | Patients discharged from Regions Hospital (St. Paul, MN) where we have implemented a standard process of printing the indication for all new medications on the prescription bottle. Receives: Other: Medication knowledge | |
| No medication indication given | Patients discharged from Brigham and Women's Hospital (Boston, MA) where there is no requirement for providing information on medication indications to patients at discharge. Receives: Other: Medication knowledge |
What is being measured
The primary outcome is the main question the study is designed to answer.
Medication Knowledge Questionnaire
Scripted questionnaire administered on patients knowledge of their medication indications who received new, changed, or continued medications at discharge via phone call. Questions are focused on understand of relationship of the medication and what symptom or disease it is teaching.
Measured: up to 5 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Apr 2017
- Study start11 Apr 2017
- Primary completion2 May 2017
- Study completion31 Oct 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medical AuditStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- HealthPartners Institute
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03125278
- Sponsor's protocol ID
- A17-072
- Status last verified
- Jun 2018
- First submitted
- 7 Apr 2017
- Last updated
- 7 Jun 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Jun 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Patient Knowledge of Medication Indication
- ClinicalTrials.gov ID
- NCT03125278
- Acronym / sponsor ID
- A17-072
- Conditions
- Medical Audit
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- HealthPartners InstituteUniversity, hospital or other
- Study start
- 11 Apr 2017 (actual)
- Primary completion
- 2 May 2017 (actual)
- Study completion
- 31 Oct 2017 (actual)
- First posted
- 24 Apr 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a study to compare patient knowledge about the indications of their medications between two sites. Regions Hospital has a population of patients that receive the medication indication on the label for any new or changed medications at the time of patient discharge. Brigham Women's Health follows a standard policy of discharge medication labels including the name of the medication and instructions for use without any indication of what the medication is intended to treat. Consented patient will receive a phone call where researchers will ask about which medications they are taking and other questions about those medications.
The study population will be patients recently discharged from the hospital with 1 or more new or changed medications
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Medication indication on the label | – | Other: Medication knowledgePatients discharged from Regions Hospital (St. Paul, MN) where we have implemented a standard process of printing the indication for all new medications on the prescription bottle. |
| No medication indication given | – | Other: Medication knowledgePatients discharged from Brigham and Women's Hospital (Boston, MA) where there is no requirement for providing information on medication indications to patients at discharge. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population will be patients recently discharged from the hospital with 1 or more new or changed medications.
Key inclusion criteria (3 listed)
- Hospital Medicine (HM) inpatient being discharged to home
- Patient being discharged with ≥ 1 new or changed medications
- English speaker
Key exclusion criteria (3 listed)
- Inpatient being discharged to nursing home or TCU facility
- Patient being discharged with no new or changed medications
- Non-English speaker
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Medication knowledgeParticipants will be asked questions over the phone about their medications | Other | Medication indication on the label, No medication indication given |
Primary outcome
Medication Knowledge Questionnaire
Time frame: up to 5 days
Scripted questionnaire administered on patients knowledge of their medication indications who received new, changed, or continued medications at discharge via phone call. Questions are focused on understand of relationship of the medication and what symptom or disease it is teaching.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jun 2018.
- Individual participant dataSharing planned: No
Related trials for Medical Audit
RecruitingObservational study
Toronto Western Hospital (TWH) Waste Audit
Audit of Medical Waste Disposal
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Medical Audit, run by HealthPartners Institute at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Medication Knowledge Questionnaire (time frame: up to 5 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2018; AzTrials last refreshed its copy on 29 Oct 2026.